Robert Francomano's most recent trade in SELLAS Life Sciences Group Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SELLAS Life Sciences Group... | Francomano Robert | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | Robert Francomano | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 20,000 | 40,918 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | Francomano Robert | Chief Commercial Officer | Other type of transaction at price $ 1.08 per share. | 06 Dec 2023 | 1,082 | 20,918 (0%) | 0% | 1.1 | 1,169 | Class A Common Stock |
| SELLAS Life Sciences Group... | Robert Francomano | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | Robert Francomano | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 12,000 | 12,000 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | Robert Francomano | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |